1-6 of 6
Lingyun Ji, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331

Patrick A. Brown, MD, Lingyun Ji, PhD, Xinxin Xu, MS, Meenakshi Devidas, PhD, Laura Hogan, MD, Michael J. Borowitz, MD PhD, Elizabeth A. Raetz, MD, Gerhard Zugmaier, Elad Sharon, MD MPH, Lia Gore, MD, James A. Whitlock, MD, Michael A. Pulsipher, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD
Journal: Blood
Blood (2019) 134 (Supplement_2): LBA-1.
https://doi.org/10.1182/blood-2019-132435
Published: 2019
Journal Articles

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Arash Mahajerin, MD MS, Julie Jaffray, MD, Amy Stillings, Emily Krava, Jemily Malvar, MS, Lingyun Ji, PhD, Richard Sposto, PhD, John H. Fargo, DO, James D. Cooper, MD, Stacy E. Croteau, Michael Silvey, DO, Nihal Bakeer, MBBS, Ali Jalali, MSME, PhD, Hannah Lonsdale, BSc, MBChB, Luis Ahumada, PhD, Neil A. Zakai, MD MSc, E Vince S Faustino, MD MHS, Neil A Goldenberg, MD PhD, Guy Young, MD, Brian R. Branchford, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 635.
https://doi.org/10.1182/blood-2019-126128
Published: 2019
Journal Articles

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621

Maureen M O'Brien, MD, Lingyun Ji, PhD, Nirali N. Shah, MD, Susan R. Rheingold, MD, Deepa Bhojwani, MD, Joanna S. Yi, MD, Constance M. Yuan, MD PhD, Andrew C Harris, MD, Patrick A. Brown, MD, Michael J. Borowitz, MD PhD, Olga Militano, PharmD, Meenakshi Devidas, PhD, Elizabeth A. Raetz, MD, Lia Gore, MD, Mignon L. Loh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 741.
https://doi.org/10.1182/blood-2019-128977
Published: 2019
Journal Articles

Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children

Julie Jaffray, MD, Sarah H. O'Brien, MD MSc, Char M Witmer, MDMSCE, Rosa Diaz, MD, Lingyun Ji, PhD, Richard Sposto, PhD, Emily Krava, Guy Young
Journal: Blood
Blood (2018) 132 (Supplement 1): 139.
https://doi.org/10.1182/blood-2018-99-115615
Published: 2018
Journal Articles

Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry

Brian R. Branchford, MD, Julie Jaffray, MD, Stacy E. Croteau, MD, Michael Silvey, DO, Nihal Bakeer, MBBS, James D. Cooper, MD, John H. Fargo, DO, Lingyun Ji, PhD, Richard Sposto, PhD, Jemily Malvar, Emily Krava, Amy Stillings, Neil A Goldenberg, MD PhD, Guy Young, Arash Mahajerin, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 142.
https://doi.org/10.1182/blood-2018-99-119968
Published: 2018
Journal Articles

Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clinical Trial AALL1331

Laura Brook Hogan, MD, Teena Bhatla, MD, Sue Rheingold, MD, Lingyun Ji, PhD, Xinxin Xu, Elizabeth A. Raetz, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Patrick Brown, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1382.
https://doi.org/10.1182/blood-2018-99-112269
Published: 2018